Meline David W 4
4 · Moderna, Inc. · Filed May 11, 2022
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Meline David W
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-05-09$134.40/sh+348$46,771→ 2,739 total - Sale
Common Stock
2022-05-10$133.71/sh−156$20,859→ 2,583 total - Exercise/Conversion
Restricted Stock Units
2022-05-09−348→ 3,830 totalExercise: $0.00→ Common Stock (348 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F3]25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.